The Indian Council of Medical Research (ICMR) has launched the Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect platform, described as India's largest biomedical innovation and technology transfer initiative. Launched at the Manekshaw Centre in New Delhi, the platform aims to connect laboratory research with commercial healthcare products, thereby accelerating the availability of medical innovations to hospitals and patients. Union Minister Prataprao Ganpatrao Jadhav emphasized that this initiative signifies India's transition from a consumer to a producer of healthcare technologies. The event marked the transfer of 41 public health technologies, including vaccines for Typhoid and Paratyphoid, diagnostic tools for Tuberculosis, and inactivated virus biomaterials for vaccine research. This platform is expected to foster collaboration among scientists, startups, and private companies, ultimately enhancing the healthcare innovation ecosystem in India. By facilitating faster commercialization of indigenous medical products, the I2I Connect platform aims to reduce reliance on imported technologies and improve access to affordable healthcare solutions across the country.